These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24358966)

  • 1. New directions in the prediction of pre-eclampsia.
    Kane SC; Da Silva Costa F; Brennecke SP
    Aust N Z J Obstet Gynaecol; 2014 Apr; 54(2):101-7. PubMed ID: 24358966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available.].
    Akush Ginekol (Sofiia); 2016; 55 Suppl 2():31-35. PubMed ID: 29470871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Screening for Early Detection of Pre-Eclampsia.
    Park HJ; Shim SS; Cha DH
    Int J Mol Sci; 2015 Aug; 16(8):17952-74. PubMed ID: 26247944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler.
    Crovetto F; Crispi F; Scazzocchio E; Mercade I; Meler E; Figueras F; Gratacos E
    Ultrasound Obstet Gynecol; 2014 Jan; 43(1):34-40. PubMed ID: 23754253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of ultrasound and other markers for early detection of preeclampsia.
    O'Gorman N; Nicolaides KH; Poon LC
    Womens Health (Lond); 2016; 12(2):199-207. PubMed ID: 26900911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine artery Doppler and prediction of preeclampsia.
    Lovgren TR; Dugoff L; Galan HL
    Clin Obstet Gynecol; 2010 Dec; 53(4):888-98. PubMed ID: 21048456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol.
    Mone F; Mulcahy C; McParland P; Stanton A; Culliton M; Downey P; McCormack D; Tully E; Dicker P; Breathnach F; Malone FD; McAuliffe FM
    Contemp Clin Trials; 2016 Jul; 49():143-8. PubMed ID: 27394381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk.
    Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):671-9. PubMed ID: 20069559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort.
    Oliveira N; Magder LS; Blitzer MG; Baschat AA
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):279-85. PubMed ID: 24913190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
    Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
    Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of preeclampsia utilizing the first trimester screening examination.
    Baschat AA; Magder LS; Doyle LE; Atlas RO; Jenkins CB; Blitzer MG
    Am J Obstet Gynecol; 2014 Nov; 211(5):514.e1-7. PubMed ID: 24746997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PRE-ECLAMPSIA: A NEW TEST FOR AN OLD DISEASE].
    Svirsky R; Feldman N; Levinsohn-Tavor O; Galoyan N; Maymon R
    Harefuah; 2018 May; 157(5):314-317. PubMed ID: 29804337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
    Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
    BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pre-eclampsia: comparative analysis of two screening tests.
    Mukhopadhyay A; Sharma P; Dasgupta S; Dasgupta S; Sharma PP; Ghosh TK
    J Indian Med Assoc; 2012 Aug; 110(8):546-7. PubMed ID: 23741819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester screening with combined maternal clinical factors, biophysical and biomarkers to predict preterm pre-eclampsia and hypertensive disorders: are they ready for clinical use?
    Sibai BM
    BJOG; 2015 Feb; 122(3):282-3. PubMed ID: 25164085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.